CLZN.Y Stock Overview
Engages in the development, manufacture, distribution, and sale of specialty chemicals worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Clariant AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 12.03 |
| 52 Week High | CHF 17.47 |
| 52 Week Low | CHF 12.03 |
| Beta | 0.72 |
| 11 Month Change | -19.83% |
| 3 Month Change | -23.60% |
| 1 Year Change | -19.57% |
| 33 Year Change | -42.93% |
| 5 Year Change | -40.44% |
| Change since IPO | 56.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLZN.Y | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -3.4% | 2.4% | 1.6% |
| 1Y | -19.6% | 12.8% | 32.3% |
Return vs Industry: CLZN.Y underperformed the US Chemicals industry which returned 12.8% over the past year.
Return vs Market: CLZN.Y underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| CLZN.Y volatility | |
|---|---|
| CLZN.Y Average Weekly Movement | 8.7% |
| Chemicals Industry Average Movement | 5.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CLZN.Y has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CLZN.Y's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1886 | 10,568 | Conrad Keijzer | www.clariant.com |
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals worldwide. The Care Chemicals segment offers specialty chemicals and application solutions for various applications in automotive fluids, aviation, construction chemicals, crop solutions, health care, home care, industrial lubricants, paints and coatings, personal care, and special solvents. The Catalysis segment provides catalyst products for use as ammonia cracking, ammonia, custom catalysts, ethylene and derivatives, fischer-tropsch, fuel cell, fuel upgrading, gas processing, hydrogen, hydrogenation, liquid hydrogen carrier, low-carbon ammonia, low-carbon methanol, methanol, methanol-to-propylene, off-gas treatment, olefins purification, on-purpose propylene, oxidation, polypropylene, refinery stream purification, styrene, zeolite powders, biocatalysis, cellulosic ethanol, cellulosic sugars, low-carbon advanced biofuels, and residue-derived biochemical intermediates.
Clariant AG Fundamentals Summary
| CLZN.Y fundamental statistics | |
|---|---|
| Market cap | US$3.96b |
| Earnings (TTM) | US$133.78m |
| Revenue (TTM) | US$4.72b |
29.6x
P/E Ratio0.8x
P/S RatioIs CLZN.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLZN.Y income statement (TTM) | |
|---|---|
| Revenue | CHF 4.16b |
| Cost of Revenue | CHF 2.94b |
| Gross Profit | CHF 1.22b |
| Other Expenses | CHF 1.10b |
| Earnings | CHF 118.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 28, 2025
| Earnings per share (EPS) | 0.36 |
| Gross Margin | 29.28% |
| Net Profit Margin | 2.83% |
| Debt/Equity Ratio | 78.3% |
How did CLZN.Y perform over the long term?
See historical performance and comparison